764 related articles for article (PubMed ID: 30844791)
1. The Effect of Serum Neutrophil Gelatinase-Associated Lipocalin on the Discontinuation of Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury.
Chen X; Chen Z; Wei T; Li P; Zhang L; Fu P
Blood Purif; 2019; 48(1):10-17. PubMed ID: 30844791
[TBL] [Abstract][Full Text] [Related]
2. Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study.
Stads S; Kant KM; de Jong MFC; de Ruijter W; Cobbaert CM; Betjes MGH; Gommers D; Oudemans-van Straaten HM
BMC Nephrol; 2019 Apr; 20(1):129. PubMed ID: 30987604
[TBL] [Abstract][Full Text] [Related]
3. Urine neutrophil gelatinase-associated lipocalin and urine output as predictors of the successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury.
Thomsen J; Sprogøe U; Toft P
BMC Nephrol; 2020 Aug; 21(1):375. PubMed ID: 32859163
[TBL] [Abstract][Full Text] [Related]
4. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute renal failure in patients with severe sepsis.
Huang CY; Shih CC; Chung K; Kao KC; Wu HP
J Chin Med Assoc; 2016 Aug; 79(8):428-34. PubMed ID: 27234975
[TBL] [Abstract][Full Text] [Related]
6. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study.
Tecson KM; Erhardtsen E; Eriksen PM; Gaber AO; Germain M; Golestaneh L; Lavoria MLA; Moore LW; McCullough PA
BMJ Open; 2017 Jul; 7(7):e016028. PubMed ID: 28698338
[TBL] [Abstract][Full Text] [Related]
7. Different Roles of Functional and Structural Renal Markers Measured at Discontinuation of Renal Replacement Therapy for Acute Kidney Injury.
Yoshida T; Matsuura R; Komaru Y; Miyamoto Y; Yoshimoto K; Hamasaki Y; Noiri E; Nangaku M; Doi K
Blood Purif; 2023; 52(9-10):786-792. PubMed ID: 37757763
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
Kümpers P; Hafer C; Lukasz A; Lichtinghagen R; Brand K; Fliser D; Faulhaber-Walter R; Kielstein JT
Crit Care; 2010; 14(1):R9. PubMed ID: 20122150
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin levels during the first 48 hours of intensive care may indicate upcoming acute kidney injury.
Kamis F; Yegenaga I; Musul M; Baydemir C; Bek S; Kalender B; Baykara N
J Crit Care; 2016 Aug; 34():89-94. PubMed ID: 27288617
[TBL] [Abstract][Full Text] [Related]
10. [Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin-18 in patients with sepsis-induced acute kidney injury].
Zhu L; Shi D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):718-22. PubMed ID: 27434563
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum neutrophil gelatinase-associated lipocalin in predicting acute kidney injury in critically ill patients.
Hang CC; Yang J; Wang S; Li CS; Tang ZR
J Int Med Res; 2017 Jun; 45(3):1231-1244. PubMed ID: 28553762
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.
Bagshaw SM; Bennett M; Haase M; Haase-Fielitz A; Egi M; Morimatsu H; D'amico G; Goldsmith D; Devarajan P; Bellomo R
Intensive Care Med; 2010 Mar; 36(3):452-61. PubMed ID: 19956924
[TBL] [Abstract][Full Text] [Related]
13. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients.
Makris K; Markou N; Evodia E; Dimopoulou E; Drakopoulos I; Ntetsika K; Rizos D; Baltopoulos G; Haliassos A
Clin Chem Lab Med; 2009; 47(1):79-82. PubMed ID: 19055468
[TBL] [Abstract][Full Text] [Related]
14. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
[TBL] [Abstract][Full Text] [Related]
15. Mortality prediction of serum neutrophil gelatinase-associated lipocalin in patients requiring continuous renal replacement therapy.
Park Y; Ban TH; Kim HD; Ko EJ; Lee J; Kim SC; Park CW; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2021 Mar; 36(2):392-400. PubMed ID: 32623875
[TBL] [Abstract][Full Text] [Related]
16. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
Wang H; Cui N; Zhou YK; Cheng W; Li L; Long Y; Liu DW
Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):285-289. PubMed ID: 29614588
[No Abstract] [Full Text] [Related]
17. Effects of continuous renal replacement therapy on serum cytokines, neutrophil gelatinase-associated lipocalin, and prognosis in patients with severe acute kidney injury after cardiac surgery.
Wang HJ; Wang P; Li N; Wan C; Jiang CM; He JS; Wang DJ; Zhang M; Sun LY
Oncotarget; 2017 Feb; 8(6):10628-10636. PubMed ID: 27833089
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.
Haase M; Bellomo R; Devarajan P; Schlattmann P; Haase-Fielitz A;
Am J Kidney Dis; 2009 Dec; 54(6):1012-24. PubMed ID: 19850388
[TBL] [Abstract][Full Text] [Related]
20. Predictors of 90-Day Restart of Renal Replacement Therapy after Discontinuation of Continuous Renal Replacement Therapy, a Prospective Multicenter Study.
Stads S; Kant KM; de Jong MFC; de Ruijter W; Cobbaert CM; Betjes MGH; Gommers D; Oudemans-van Straaten HM
Blood Purif; 2019; 48(3):243-252. PubMed ID: 31330511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
